
Cabedac 0.25mg Tablet
Marketer
Innovative Pharmaceuticals
Salt Composition
Cabergoline (0.25mg)
Overview Cabedac 0.25mg Tablet
Bromocriptine 0.25mg tablets function as a dopamine receptor stimulant, indicated for managing hyperprolactinemia. This medication also aids in suppressing lactation following stillbirth, abortion, or miscarriage. Administer Bromocriptine 0.25mg tablets with food, maintaining consistent daily timing for optimal efficacy. Dosage and frequency are determined by your physician based on your specific condition. Your doctor will adjust the dosage to effectively manage your symptoms. Ingest tablets whole with water. Continue treatment for the prescribed duration. Commonly reported side effects include nausea, headache, lightheadedness, and hypotension. Report any concerning or persistent side effects to your physician; management strategies may be available. To mitigate dizziness, avoid driving and rise gradually from a seated or recumbent position. Prior to commencing treatment, inform your physician of any history of postpartum hypertension or cardiac disease. Disclose any current or planned pregnancy or breastfeeding. Complete disclosure of all other medications is crucial, as interactions may reduce Bromocriptine's effectiveness or alter its action. Regular blood pressure monitoring may be undertaken during treatment.
Uses of Cabedac 0.25mg Tablet
Managing hyperprolactinemia
Major Benefits of Cabedac 0.25mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Cabedac 0.25mg Tablet should be administered with a meal.
Common Side effects of Cabedac 0.25mg Tablet:
- Nausea
- Constipation
- Dizziness
- Fatigue
- Headache
- Vomiting
- Vertigo
- Abdominal pain
- Breast pain
- Sleepiness
- Valvulopathy and related disorders
- Dyspepsia
- Gastritis
- Weakness
- Depression
- Postural hypotension (low blood pressure)
- Hot flushes
How to use Cabedac 0.25mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 0.25mg Cabedac tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
How Cabedac 0.25mg Tablet works:
Cabedac 0.25mg tablets reduce prolactin hormone levels, thereby suppressing lactation. This action halts breast milk production following stillbirth, abortion, or miscarriage.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Cabedac 0.25mg tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Cabedac 0.25mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefit outweighs the risk. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Cabedac 0.25mg tablets while breastfeeding is likely unsafe. Available evidence indicates potential transfer to breast milk, posing a risk to the infant. Cabedac 0.25mg tablets are typically avoided during lactation due to their lactation-suppressing effect.
DrivingUNSAFE
Taking a 0.25mg Cabedac tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Cabedac 0.25mg tablets appear to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
For individuals with liver impairment, the administration of 0.25mg Cabedac tablets requires careful monitoring. A modified dosage of Cabedac 0.25mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Cabedac 0.25mg Tablet :
Omit a missed dose of Cabedac 0.25mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cabedac 0.25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Ergoline alkaloids |
| Developing Habits | No. |
| Type of Therapy | Obstetrics and Gynecology |
| Action Class | Elevated Prolactin Levels with Dopamine Agonist Use |
